Trial Profile
A multi-centric, prospective, randomized, double blind study to evaluate the safety and efficacy of 2mg and 4mg of ZYH1 compared to placebo in hypertriglyceridemia with type II diabetes not controlled with Atorvastatin therapy.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Aug 2016
Price :
$35
*
At a glance
- Drugs Saroglitazar (Primary) ; Atorvastatin
- Indications Hypertriglyceridaemia
- Focus Registrational; Therapeutic Use
- Acronyms PRESS VI
- 12 Jun 2012 Results presented at the 72nd Annual Scientific Sessions of the American Diabetes Association.
- 18 Jan 2012 Status changed from active, no longer recruiting to completed, as reported by Clinical Trials Registry - India record
- 23 Dec 2010 Status changed from recruiting to active, no longer recruiting as reported by Clinical Trials Registry - India record.